To further determine whether compound 7 and ISJ represent potential candidates for selective PKC expression inhibitors against hepatoma, the expression of PKC isoforms in HepG2 cells was characterized by western blotting. This evidence concerns the gene PRRT2 and hepatocellular carcinoma.